4SC-102

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug Name4SC-102
Drug Alias Name4SC-102
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammationInflammatory Bowel DiseasesArthritis, Rheumatoid +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator Companies4sc Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4sc Ag
Active IndicationsN/A
Inactive IndicationsInflammationInflammatory Bowel DiseasesArthritis, Rheumatoid +[6] 

Other Information

ATC CodeN/A
Related LinksN/A